India  
 
NewsR.in

United States: Mintz IRA Update — The IRA In 2024: The Medicare Drug Price Negotiation Program In Full Swing And Other Developments - Mintz

Mondaq Monday, 4 March 2024
Our team's preparation for the year includes a review of the anticipated impact of the IRA on the health care industry in 2024.
0
shares		ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Nvidia & darpa biohybrid [Video]

Nvidia & darpa biohybrid

https://www.youtube.com/watch?v=0Hg7XhbXuac . No One is Talking About What Just Happened..

Credit: Rumble     Duration: 55:45Published

Related news from verified sources

United States: Mintz IRA Update — Legal Challenges To The Medicare Drug Price Negotiation Program Continue - Mintz

 The IRA's Medicare Drug Price Negotiation Program (the "Negotiation Program" or "Program"), which aims to lower drug prices by enabling the federal government to...
Mondaq

United States: Mintz IRA Update — Demystifying The IRA's Small Biotech Exception - Mintz

 On August 29, 2023, CMS selected the first 10 high-expenditure, single source, Medicare Part D drugs subject to negotiation under the IRA's Medicare Drug Price...
Mondaq